Streetbeat News

Products Services

CVKD

Cadrenal Therapeutics is set to have a Type-B meeting with the FDA in September to discuss the development of tecarfarin for LVAD patients. This meeting is a significant step towards their pivotal trial.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:04 pm

ZK

Zeekr, a luxury EV brand under Geely, plans to launch a hybrid SUV in 2025, marking a shift from its BEV focus. This move aligns with consumer preferences for hybrids to avoid range anxiety. Zeekr's stock (NYSE:ZK) is trading lower by 1.31% premarket.

Portfolio Pulse from Nabaparna Bhattacharya

August 22, 2024 | 1:03 pm

CVX

Chevron Corporation has been awarded a greenhouse gas assessment permit offshore Western Australia, enhancing its carbon capture and storage portfolio. This aligns with Chevron's strategy to deliver lower carbon energy.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:03 pm

AZTR

Azitra, Inc. has received FDA clearance for a Phase 1/2 clinical study of ATR-04, targeting skin rash from EGFR inhibitors. This condition affects 150,000 patients in the US, representing a market size of over $1 billion. Preclinical data shows ATR-04's potential in reducing key rash drivers.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:01 pm

ACN

AMZN

Accenture has expanded its collaboration with Amazon Web Services (AWS) to launch a Responsible AI platform. This platform aims to help enterprises scale AI solutions with trust and confidence.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 1:00 pm

MSOS

MSOX

The cannabis market is facing volatility, with ETFs like AdvisorShares Pure US Cannabis ETF (MSOS) and its leveraged counterpart MSOX experiencing challenges due to regulatory uncertainty and underperforming stocks. However, potential regulatory reforms, such as cannabis rescheduling, offer hope for recovery.

Portfolio Pulse from Javier Hasse

August 22, 2024 | 1:00 pm

BIDU

IQ

Baidu reported Q2 revenue of $4.67 billion, slightly below expectations, but exceeded earnings estimates with $2.89 per ADS. Baidu's AI Cloud business grew, offsetting declines in online marketing. Baidu's stock traded lower by 0.80% in premarket.

Portfolio Pulse from Anusuya Lahiri

August 22, 2024 | 12:57 pm

PLTR

Palantir Technologies, Inc. (NYSE:PLTR) is recognized as a leader in the enterprise AI market by Northland Capital Markets analyst Michael Latimore. Despite its strengths, including a proprietary AI platform and a growing enterprise segment, the analyst gives it a Market Perform rating with a $35 price target, suggesting limited upside. Palantir's AI system enhances data utility without costly overhauls, and its market is expanding rapidly. The analyst suggests buying on dips.

Portfolio Pulse from Shanthi Rexaline

August 22, 2024 | 12:54 pm

ABVE

Above Food has expanded its pet food business to $110 million in revenue by acquiring TRG's Specialty Crop Food Ingredient Division. This acquisition strengthens its position in the $26 billion global plant-based pet food market, allowing for rapid response to the growing demand for sustainable pet nutrition through vertical integration.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:48 pm